跳至主要内容
临床试验/CTRI/2024/03/064453
CTRI/2024/03/064453尚未招募3 期

Perampanel vs Levetiracetam as first line anti-epileptic drug in adult patients with new onset focal seizures: An open labelled, non-inferiority, randomized trial - nil

AIIMS Bhubaneswar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age more than or equal to 18 years
  • Those willing to give consent
  • First time detected new onset focal seizures with or without secondary generalization

排除标准

  • Pregnant women
  • Patients with current or previous seizure semiologies other than focal seizures
  • Generalized epilepsy syndrome
  • EEG findings suggestive of idiopathic generalized epilepsy
  • Patients presenting with status epilepticus
  • Acute or chronic kidney disease with creatinine clearance less than 30 ml per min

研究者

相似试验